Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus
By the spring of 2020 the COVID-19 outbreak caused by the new SARS-CoV-2 coronavirus has become a pandemic, requiring fast and efficient reaction from societies and health care systems all over the world. Fever, coughing and dyspnea are considered the major signs of COVID-19. In addition to the involvement of the respiratory system, the infection may result in other symptoms and signs as well. Based on reports to date, neurological signs or symptoms appear in 30-50% of hospitalized COVID-19 patients, with higher incidence in those with more severe disease. Classical acute neurological syndromes have also been reported to associate with COVID-19. A drop in the volume of services for other acute diseases has been described in countries with healthcare systems focusing on COVID-19. During the COVID-19 epidemic it is also important to provide appropriate continuous care for those with chronic neurological disorders. It will be the task of the future to estimate the collateral damage caused by the COVID-19 epidemic on the outcome of other neurological disorders, and to screen for the possible late neurological complications of the SARS-CoV-2 coronavirus infection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
Ideggyogyaszati szemle - 73(2020), 05-06 vom: 30. Mai, Seite 171-175 |
| Sprache: |
Ungarisch |
|---|
| Weiterer Titel: |
A SARS-CoV-2 koronavírus által okozott COVID-19-járvány neurológiai vonatkozásai |
|---|
| Beteiligte Personen: |
Bereczki, Dániel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 29.06.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.18071/isz.73.0171 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311577237 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311577237 | ||
| 003 | DE-627 | ||
| 005 | 20231225142541.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||hun c | ||
| 024 | 7 | |a 10.18071/isz.73.0171 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1038.xml |
| 035 | |a (DE-627)NLM311577237 | ||
| 035 | |a (NLM)32579306 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a hun | ||
| 100 | 1 | |a Bereczki, Dániel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus |
| 246 | 3 | 3 | |a A SARS-CoV-2 koronavírus által okozott COVID-19-járvány neurológiai vonatkozásai |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.06.2020 | ||
| 500 | |a Date Revised 18.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a By the spring of 2020 the COVID-19 outbreak caused by the new SARS-CoV-2 coronavirus has become a pandemic, requiring fast and efficient reaction from societies and health care systems all over the world. Fever, coughing and dyspnea are considered the major signs of COVID-19. In addition to the involvement of the respiratory system, the infection may result in other symptoms and signs as well. Based on reports to date, neurological signs or symptoms appear in 30-50% of hospitalized COVID-19 patients, with higher incidence in those with more severe disease. Classical acute neurological syndromes have also been reported to associate with COVID-19. A drop in the volume of services for other acute diseases has been described in countries with healthcare systems focusing on COVID-19. During the COVID-19 epidemic it is also important to provide appropriate continuous care for those with chronic neurological disorders. It will be the task of the future to estimate the collateral damage caused by the COVID-19 epidemic on the outcome of other neurological disorders, and to screen for the possible late neurological complications of the SARS-CoV-2 coronavirus infection | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a collateral damage | |
| 650 | 4 | |a neurological diseases | |
| 650 | 4 | |a neurological services | |
| 650 | 4 | |a neurological signs | |
| 700 | 1 | |a Stang, Rita |e verfasserin |4 aut | |
| 700 | 1 | |a Böjti, Péter |e verfasserin |4 aut | |
| 700 | 1 | |a Kovács, Tibor |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Ideggyogyaszati szemle |d 1954 |g 73(2020), 05-06 vom: 30. Mai, Seite 171-175 |w (DE-627)NLM119915138 |x 0019-1442 |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2020 |g number:05-06 |g day:30 |g month:05 |g pages:171-175 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18071/isz.73.0171 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2020 |e 05-06 |b 30 |c 05 |h 171-175 | ||